Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Marcandalli

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Microbiology|June 4, 2019
HCMV Envelope Glycoprotein Diversity DemystifiedMathilde Foglierini, Jessica Marcandalli, Laurent Perez
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2012
Purinergic P2X7 receptor drives T cell lineage choice and shapes peripheral γδ cellsMichela Frascoli, Jessica Marcandalli, Ursula Schenk, et al.
Plos Pathogens|December 28, 2020
Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicityMichela Perotti, Jessica Marcandalli, Davide Demurtas, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodiesAnna Kabanova, Laurent Perez, Daniele Lilleri, et al.
Nature|August 20, 2013
Cross-neutralization of four paramyxoviruses by a human monoclonal antibodyDavide Corti, Siro Bianchi, Fabrizia Vanzetta, et al.
Cell|July 31, 2018
An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral ReceptorNadia Martinez-Martin, Jessica Marcandalli, Christine S Huang, et al.
Nature Microbiology|August 31, 2016
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimerAnna Kabanova, Jessica Marcandalli, Tongqing Zhou, et al.
Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.
Cell|March 9, 2019
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial VirusJessica Marcandalli, Brooke Fiala, Sebastian Ols, et al.
Immunity|September 9, 2023
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumovirusesSebastian Ols, Klara Lenart, Rodrigo Arcoverde Cerveira, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Microbiology|June 4, 2019
HCMV Envelope Glycoprotein Diversity DemystifiedMathilde Foglierini, Jessica Marcandalli, Laurent Perez
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2012
Purinergic P2X7 receptor drives T cell lineage choice and shapes peripheral γδ cellsMichela Frascoli, Jessica Marcandalli, Ursula Schenk, et al.
Plos Pathogens|December 28, 2020
Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicityMichela Perotti, Jessica Marcandalli, Davide Demurtas, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodiesAnna Kabanova, Laurent Perez, Daniele Lilleri, et al.
Nature|August 20, 2013
Cross-neutralization of four paramyxoviruses by a human monoclonal antibodyDavide Corti, Siro Bianchi, Fabrizia Vanzetta, et al.
Cell|July 31, 2018
An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral ReceptorNadia Martinez-Martin, Jessica Marcandalli, Christine S Huang, et al.
Nature Microbiology|August 31, 2016
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimerAnna Kabanova, Jessica Marcandalli, Tongqing Zhou, et al.
Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.
Cell|March 9, 2019
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial VirusJessica Marcandalli, Brooke Fiala, Sebastian Ols, et al.
Immunity|September 9, 2023
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumovirusesSebastian Ols, Klara Lenart, Rodrigo Arcoverde Cerveira, et al.
Pageof 1